亚洲知识产权资讯网为知识产权业界提供一个一站式网上交易平台,协助业界发掘知识产权贸易商机,并与环球知识产权业界建立联系。无论你是知识产权拥有者正在出售您的知识产权,或是制造商需要购买技术以提高操作效能,又或是知识产权配套服务供应商,你将会从本网站发掘到有用的知识产权贸易资讯。

A Novel Anti-Cancer/Anti-Proliferation and Anti-Migration Compound—An Inhibitor to Dual Specificity Phosphatase Slingshot-2

技术优势
Highly specific SSH-2 inhibitor that regulates F-actin depolymerization.
技术应用
New therapeutics, targeting actin filament dynamics and signaling pathways, for the treatment of cancer, Alzheimer’s, and other diseases.
详细技术说明
Scientists at UC San Diego have found a family of small molecule inhibitors that specifically binds to SSH-2. These compounds represent the first inhibitors of a phosphatase that regulates the F-actin depolymerization.The inventors used a molecular docking simulation software (DOCK 6.0) to virtually screen open-source chemical databases and determined the binding affinities to 18 of DSPs with known three-dimensional structures as determined by x-ray crystallography, including SSH-2, VHR (DUSP3), VHY (DUSP15), VHZ (DUSP23), VH1 (DUSP12), VH3 (DUSP5), PTEN (phosphatase and tensin homolog), KAP (Cdk2 associated protein phosphatase), MKP3 (rVH6, Pyst1), MKP4, MKP5, MTMR2, DUSP18, PRL3, CDC14b, Pac-1, Jsp-1, and TMPD. Five compounds with similar chemical structures have the highest affinity for SSH-2, but lowest affinity for the other DSPs, among the best 100 SSH-2 binding compounds. Figure 1. Diagram illustrating the role of phosphorylation and SSH-2 in actin filament assembly.
*Abstract
Cell growth and movement are controlled in part through the activation of a dual specificity phosphatase (DSP) called Slingshot-2 (SSH-2). SSH-2 is known to contribute to the progression of cancer and Alzheimer’s disease. Therefore, finding a specific inhibitor for SSH-2 may have a profound impact in clinical treatments of these diseases.
*IP Issue Date
Nov 8, 2016
*Principal Investigation

Name: Shu Chien

Department:


Name: Jason Haga

Department:


Name: Marshall Levesque

Department:


Name: Matt Mui

Department:


Name: Phillip Pham

Department:

主要类别
诊断/治疗
细分类别
癌症/肿瘤
申请号码
9487522
其他

State Of Development

Virtual screening yielded a compound with high binding affinity to SSH-2 and very low binding affinity to other DSPs.


Related Materials

Mui MK , Levesque MJ, Chien S, and Haga JH. In-Silico Identification of High Potential SSH-2 Specific Inhibitors. The FASAB J. (1_MeetingAbstracts) Apr 2010; 24 No. 1060.3.


Tech ID/UC Case

21653/2010-247-0


Related Cases

2010-247-0

国家/地区
美国

欲了解更多信息,请点击 这里
移动设备